Skip to content
Lower risk Drug recall · FDA · Published September 20, 2016

Leiter's Compounding Ophthalmic Solution Recall: Sterility Risk

Leiter's Compounding recalls cyclopentolate, tropicamide, and phenylephrine eye drops due to lack of sterility assurance in compounded products. All unexpired lots from specific NDC numbers are affected.

🇺🇸 FDA recall #D-0013-2017DrugLeiter's Compounding ›
Take action

Contact the company

Recalling firmLeiter's Compounding17 Great Oaks Blvd · San Jose, CA 95119-1359
✎ GovInfoNow plain-language explainer

What happened, in plain English

Leiter's Compounding has recalled certain eye drop solutions because they were compounded without proper sterility assurance. This could lead to infections if used improperly. Affected products include specific volumes and expiration dates. Read more at govinfonow.com/recall/42421-leiter-s-compounding-ophthalmic-solution-recall-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/42421-leiter-s-compounding-ophthalmic-solution-recall-sterility-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0013-2017

Cite this page

“Leiter's Compounding Ophthalmic Solution Recall: Sterility Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42421-leiter-s-compounding-ophthalmic-solution-recall-sterility-risk. Based on FDA recall #D-0013-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0013-2017%22&limit=1).

Why it’s dangerous

The eye drops were compounded using filters that did not ensure sterility, which could lead to infections if the product is used. This is a risk during medical procedures where sterile solutions are required.

Who’s affected

People who have the recalled eye drops (1 mL or 10 mL in 15 mL dropper bottles) with unexpired lots from the listed dates. Those using these drops for eye treatments are most at risk.

How to tell if you have this one

Check for the 1 mL or 10 mL total volume in a 15 mL dropper bottle with NDC numbers 70360-017-38 or 70360-017-39. The products were made between specific expiration dates listed in the recall.

  • Brand
    Leiter's Compounding
  • Category
    Drug
FDA recall event · 9 products

All 9 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lots
D-0010-2017Atropine Sulfate 0.01% in 0.9% Sodium Chloride (Ophthalmic Solution) 10 mL Total Volume in a 15 mL Dropper Bottle, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-011-39; All unexpired lots; Expirations dates of 11/13/2016 to 01/02/2017
D-0011-2017Brilliant Blue G 0.025% in 0.9% Sodium Chloride (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-008-35; All unexpired lots; Expirations dates of .09/20/2016 to 10/10/2016
D-0012-2017Cefuroxime Sodium 10 mg/mL in 0.9% Sodium Chloride (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-007-35; All unexpired lots; Expirations dates of 09/24/2016 to 02/06/2017
D-0013-2017Cyclopentolate HCl 1% - Tropicamide 1% - PHENYLephrine HCl 2.5% in Sterile Water for Injection (Ophthalmic Solution), in a) 1 mL Total Volume (NDC 70360-017-38) and b) 10 mL Total Volume (NDC 70360-017-39) in a 15 mL Dropper Bottle, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-017-38; All unexpired lots; a) Expirations dates of 10/03/2016 to 11/06/2016 and b) 09/25/2016 to 10/01/2016
D-0014-2017Lidocaine HCl 1% - Phenylephrine HCl 1.5% in Sterile Water for Injection (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-002-35; All unexpired lots; Expirations dates of 10/03/2016 to 12/19/2016
D-0015-2017Mitomycin 0.02% (0.2 mg/mL) in Sterile Water for Injection (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-005-35; All unexpired lots; Expirations dates of .11/05/2016 to 12/10/2016.
D-0016-2017Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS) Intravitreal Injection, 1 mL Total Volume in a 2 mL Vial, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-003-35; All unexpired lots; Expirations dates of 09/21/2016 to 2/2/2017
D-0017-2017Placebo for Prednisolone Acetate 1%, Oph Suspension, 10 mL Dropper Bottle, Compounded by Leiter's Compounding, San Jose, CA; All unexpired lots; Expirations dates of 10/11/2016 to 01/16/2017
D-0018-2017Vancomycin 10 mg/mL in 0.9% Sodium Chloride (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-005-35; All unexpired lots; Expirations dates of 10/05/2016 to 01/10/2017
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the NDC numbers 70360-017-38 or 70360-017-39 and expiration dates listed in the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Sep 20, 201612. FDA classified it Class II: Oct 12, 201623. Published in FDA’s Enforcement Report: Oct 19, 201634. FDA terminated the recall: May 3, 2017420162017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0013-2017 (September 20, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0013-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA